CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...
In 2016, CTS tested more source plasma samples (4.9 million) than blood donor samples (4.5 million).
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...